Tyvaso Dosing and Titration Evaluation: TyTRATE Registry
NCT ID: NCT01799473
Last Updated: 2015-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
98 participants
OBSERVATIONAL
2013-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A call-center will contact the patients directly at weeks 1, 2, 3, 4, 8, 12, 16, 20, and 24 to review their dose and titration schedule. In addition to patient-reported dosing data, some patient demographic information, will be collected by the investigative site at Baseline.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
NCT01266265
Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
NCT03950739
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT01477333
An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
NCT00454558
Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
NCT02893995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are willing and able to be contacted by the patient call center.
Exclusion Criteria
* Are currently enrolled in an interventional (non-FDA approved) PH clinical trial.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Regents of the University of California
La Jolla, California, United States
UCLA Medical Center
Los Angeles, California, United States
Southern California Permanente
Pasadena, California, United States
Central Coast Chest Consultants
San Luis Obispo, California, United States
Pacific Sleep Disorders Center
Stockton, California, United States
Prime Healthcare, PC
West Hartford, Connecticut, United States
Bay Area Cardiology Associates, PA
Brandon, Florida, United States
Florida Lung & Sleep Specialist
Celebration, Florida, United States
Jacksonville, Florida, United States
Sacred Heart Medical Group
Miramar Beach, Florida, United States
Cardiology Consultants
Pensacola, Florida, United States
Pensacola Lung Group
Pensacola, Florida, United States
Sacred Heart Medical Group
Pensacola, Florida, United States
Pediatrix Cardiology Associates
Tampa, Florida, United States
Doctors Hospital of Augusta
Augusta, Georgia, United States
On Site Clinical Solutions
Cumming, Georgia, United States
Duluth Biomedical Research
Duluth, Georgia, United States
Gwinnett Consultants in Cardiology
Lawrenceville, Georgia, United States
Atlanta Cardiology Consultants
Roswell, Georgia, United States
Queens Medical Center - Honolulu
‘Aiea, Hawaii, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Dor Heart and Vascular Clinic
Gurnee, Illinois, United States
Loyola University of Chicago
Maywood, Illinois, United States
Advocate Medical Group
Oak Brook, Illinois, United States
Methodist Medical Center of Illinois
Peoria, Illinois, United States
Clarian Health Methodist Hospital
Indianapolis, Indiana, United States
MedStar Health Institute
Hyattsville, Maryland, United States
Pulmonary and Care Associates of Baltimore
Pikesville, Maryland, United States
Madison Medical Affiliates
Milwaukee, Michigan, United States
Singing River Health System
Pascagoula, Mississippi, United States
AZ Perfection Clinical
Union, New Jersey, United States
Presbyterian Heart Group
Albuquerque, New Mexico, United States
Heart and Lung Associates, PC
Bayside, New York, United States
New York Methodist Hospital
Brooklyn, New York, United States
Asheville Cardiology Associates
Asheville, North Carolina, United States
Sanford Heart Hospital
Fargo, North Dakota, United States
Children's Hospital Medical Center
Cincinnati, Ohio, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Midwest Pulmonary & Sleep Research
Dayton, Ohio, United States
Southwest General Health Center
Middleburg Heights, Ohio, United States
INTEGRIS Baptist Medical Center, Inc
Oklahoma City, Oklahoma, United States
The Lankenau Institute for Medical Research
Wynnewood, Pennsylvania, United States
WellSpan Health
York, Pennsylvania, United States
Maury Regional Medical Center
Columbia, Tennessee, United States
Pulmonary Consultants of San Antonio, PA
San Antonio, Texas, United States
The Rector and Visitors of the University of Virginia
Charlottesville, Virginia, United States
Carilion Medical Center
Roanoke, Virginia, United States
Pulmonary & Sleep Research
Spokane, Washington, United States
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
The Medical College of Wisconsin, Inc.
Milwaukee, Wisconsin, United States
CardioPulmonary Research Center
Guaynabo, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIN-PH-404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.